Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression

While TGFβ plays a critical role in tumor formation and progression, the role and contribution of its three different isoforms remain unclear. In this study, we aimed at elucidating the prognostic value of the TGFβ isoforms and assessed their expression levels in breast cancer patients at different...

Full description

Saved in:
Bibliographic Details
Main Authors: Mahmood Y Hachim, Ibrahim Y Hachim, Meiou Dai, Suhad Ali, Jean-Jacques Lebrun
Format: Article
Language:English
Published: SAGE Publishing 2018-01-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317748254
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839601190725222400
author Mahmood Y Hachim
Ibrahim Y Hachim
Meiou Dai
Suhad Ali
Jean-Jacques Lebrun
author_facet Mahmood Y Hachim
Ibrahim Y Hachim
Meiou Dai
Suhad Ali
Jean-Jacques Lebrun
author_sort Mahmood Y Hachim
collection DOAJ
description While TGFβ plays a critical role in tumor formation and progression, the role and contribution of its three different isoforms remain unclear. In this study, we aimed at elucidating the prognostic value of the TGFβ isoforms and assessed their expression levels in breast cancer patients at different stages of the disease. We found higher levels of TGFβ1 and TGFβ3 in cancer patients compared to normal tissues, with no significant changes in TGFβ2 expression. Similarly, TGFβ1 and TGFβ3, but not TGFβ2, showed higher expression levels in advanced lymph node–positive and metastatic tumors, suggesting different roles for the different isoforms in tumor progression and the metastatic process, while in the least aggressive molecular subtype (luminal A), expression of the three TGFβ isoforms significantly correlated with expression of both TGFβ receptors, such correlation only occurred between TGFβ1 and TGFβ3 and the TGFβ type II receptor (TβRII) in the highly aggressive basal-like subtype. Interestingly, a distinct and somehow opposite pattern was observed in HER-2 tumors, only showing significant association pattern between TGFβ2 and the TGFβ type I receptor (TβRI). Finally, the three TGFβ isoforms showed distinct association patterns with patient outcome depending on the different molecular subtype, highlighting context-dependent, differential prognostic values.
format Article
id doaj-art-71a84adfb8b54f9eb320898b6dc5e11a
institution Matheson Library
issn 1423-0380
language English
publishDate 2018-01-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-71a84adfb8b54f9eb320898b6dc5e11a2025-08-02T10:53:46ZengSAGE PublishingTumor Biology1423-03802018-01-014010.1177/1010428317748254Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progressionMahmood Y Hachim0Ibrahim Y Hachim1Meiou Dai2Suhad Ali3Jean-Jacques Lebrun4Sharjah Institute for Medical Research, University of Sharjah, Sharjah, UAECancer Research Program, Department of Medicine, McGill University Health Centre, Montreal, QC, CanadaCancer Research Program, Department of Medicine, McGill University Health Centre, Montreal, QC, CanadaCancer Research Program, Department of Medicine, McGill University Health Centre, Montreal, QC, CanadaCancer Research Program, Department of Medicine, McGill University Health Centre, Montreal, QC, CanadaWhile TGFβ plays a critical role in tumor formation and progression, the role and contribution of its three different isoforms remain unclear. In this study, we aimed at elucidating the prognostic value of the TGFβ isoforms and assessed their expression levels in breast cancer patients at different stages of the disease. We found higher levels of TGFβ1 and TGFβ3 in cancer patients compared to normal tissues, with no significant changes in TGFβ2 expression. Similarly, TGFβ1 and TGFβ3, but not TGFβ2, showed higher expression levels in advanced lymph node–positive and metastatic tumors, suggesting different roles for the different isoforms in tumor progression and the metastatic process, while in the least aggressive molecular subtype (luminal A), expression of the three TGFβ isoforms significantly correlated with expression of both TGFβ receptors, such correlation only occurred between TGFβ1 and TGFβ3 and the TGFβ type II receptor (TβRII) in the highly aggressive basal-like subtype. Interestingly, a distinct and somehow opposite pattern was observed in HER-2 tumors, only showing significant association pattern between TGFβ2 and the TGFβ type I receptor (TβRI). Finally, the three TGFβ isoforms showed distinct association patterns with patient outcome depending on the different molecular subtype, highlighting context-dependent, differential prognostic values.https://doi.org/10.1177/1010428317748254
spellingShingle Mahmood Y Hachim
Ibrahim Y Hachim
Meiou Dai
Suhad Ali
Jean-Jacques Lebrun
Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression
Tumor Biology
title Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression
title_full Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression
title_fullStr Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression
title_full_unstemmed Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression
title_short Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression
title_sort differential expression of tgfβ isoforms in breast cancer highlights different roles during breast cancer progression
url https://doi.org/10.1177/1010428317748254
work_keys_str_mv AT mahmoodyhachim differentialexpressionoftgfbisoformsinbreastcancerhighlightsdifferentrolesduringbreastcancerprogression
AT ibrahimyhachim differentialexpressionoftgfbisoformsinbreastcancerhighlightsdifferentrolesduringbreastcancerprogression
AT meioudai differentialexpressionoftgfbisoformsinbreastcancerhighlightsdifferentrolesduringbreastcancerprogression
AT suhadali differentialexpressionoftgfbisoformsinbreastcancerhighlightsdifferentrolesduringbreastcancerprogression
AT jeanjacqueslebrun differentialexpressionoftgfbisoformsinbreastcancerhighlightsdifferentrolesduringbreastcancerprogression